Please ensure Javascript is enabled for purposes of website accessibility
Corinne Cardina

Corinne Cardina

TMFccardina

Recent articles

GettyImages-1213070451

Coronavirus Vaccine Stocks: Is There Room For Multiple Winners?

Pfizer and Moderna are leading the pack, but they're far from being the only companies likely to launch COVID-19 vaccines on the market.


GettyImages-1160789077

Is This Weight Loss Company Coming for WW And Noom's Market Share?

Digital health investors should take notice of Lifesum, a food tracking app with 45 million members and partnerships with Amazon and Nike.


GettyImages-1127763296 (1)

Ask A Virologist: How Does GlaxoSmithKline's Potential Coronavirus Vaccine Work?

Dr. Angela Rasmussen explains what investors should know about an under-the-radar coronavirus vaccine developer.


GettyImages-1210040522

What The Flu Shot's History Tells Us About Coronavirus Vaccines

We sat down with a pandemic expert to find out how the eventual coronavirus vaccines will be similar to and different from the flu shot.


GettyImages-1213070451

What Investors Need To Know About Pfizer's Coronavirus Vaccine And Ultra-Cold Storage Requirements

A doctor and pandemic expert explains how the need to keep vaccine doses ultra-cold may impact distribution.

GettyImages-1211115025 (1)

Could Late-Stage Coronavirus Vaccine Trials Fail?

Dr. Jeremy Brown says that historically, 90% of vaccine trials fail. Does this data still hold or has the game changed?


GettyImages-1215518076

Pandemic Expert Answers: 'Do You Foresee Challenges with Vaccine Distribution?'

Investors have questions about the cold chain, particularly for Pfizer's potential vaccine.


GettyImages-1210040522

Ask A Virologist: What's The Timeline for Coronavirus Vaccine Distribution?

Dr. Angela Rasmussen answers the million-dollar question on everyone's mind.


GettyImages-1127763296 (1)

Thinking About Buying Coronavirus Vaccine Stocks? Watch This First

Dr. Jeremy Brown gives investors a helpful tip about valuation


GettyImages-641861844

What Investors Need To Know About Companies Working on Coronavirus Vaccines

Dr. Leo Nissola shares 1 major thing investors should consider before buying coronavirus vaccine stocks.

GettyImages-1227122484

How Is Digital Health Disrupting Traditional Healthcare Companies?

Here's what investors need to know about how telehealth and technology is changing the healthcare landscape.


GettyImages-1208116440

Could The Coronavirus Pandemic Mean Fewer Flu Deaths This Year?

Dr. Jeremy Brown shares how COVID-19 will impact the seasonal flu.


GettyImages-1227122484

Are Digital Health Valuations Overhyped Or Undervalued?

A digital health CEO shares what investors need to know about stocks like Teladoc and Veeva Systems.


GettyImages-909176662 (1)

Ask An Expert: How Do Experimental mRNA Vaccines Differ From Traditional Vaccines?

Here's what Dr. Jeremy Brown thinks about the exciting trial data from Pfizer and Moderna.


GettyImages-1282791442

A Doctor Explains: Safety Tips For Avoiding The Coronavirus In The Winter Months And Holidays

Dr. Jeremy Brown knows a lot about pandemics. Here's his advice on keeping your family safe.

GettyImages-641861844

Is Pfizer and BioNTech's Potential mRNA Coronavirus Vaccine Revolutionary?

Dr. Leo Nissola shares what investors need to know about the latest developments in the mRNA vaccine space.


GettyImages-1174616486

Nutrition App CEO On The Health and Wellness Industry During The Coronavirus Pandemic

This start-up is helping people lose weight by tracking their food, and its partnerships with Amazon and Nike are just the beginning.


GettyImages-1215565992

Is Pfizer Stock A Good Bet On Coronavirus Vaccines?

Dr. Angela Rasmussen shares tips for investors thinking about buying stocks like Pfizer and Moderna.


GettyImages-1170651234

This Digital Health Startup Has Joined Forces With Amazon. Should Investors Take Notice?

Lifesum has forged partnerships with many popular tech companies. Is an IPO on the horizon?


GettyImages-1210040522

Why Ultra-Cold Storage and Two-Dose Shots Could Spell A Logistical Nightmare for Pfizer

Pfizer's coronavirus vaccine candidate comes with two hurdles that might give its competitors an edge.